Early Phase 1 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who gave birth between 12 weeks and 5 years ago
- People who had a normal pregnancy and did not take low-dose aspirin during that pregnancy
- People who had a normal pregnancy and did take low-dose aspirin during that pregnancy
- People who had preeclampsia (a pregnancy complication involving high blood pressure) and did not take low-dose aspirin during that pregnancy
- People who had preeclampsia and did take low-dose aspirin during that pregnancy
Who may not be able to join:
- People who currently take aspirin every day
- People who have a skin condition or skin disease
- People who currently use tobacco products
- People who have been diagnosed with, or are suspected of having, a liver or metabolic disease, or a kidney disease where kidney function is significantly reduced
- People who currently take statins or any other medication to lower cholesterol
- People who currently take medication to lower blood pressure
- People who had high blood pressure before their pregnancy
- People who have a history of gestational diabetes (high blood sugar during pregnancy)
- People who are currently pregnant
- People whose body weight is considered underweight based on a standard height-to-weight calculation (confirm with trial site)
- People who have an allergy to materials that may be used during the study, such as latex
- People who have a known allergy to the study drugs
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 319-467-1732
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
microvascular endothelial function; microvascular endothelin-1-mediated constriction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.